CNXC
Income statement / Annual
Last year (2025), Concentrix Corp.'s total revenue was $9.83 B,
an increase of 2.15% from the previous year.
In 2025, Concentrix Corp.'s net income was -$1.28 B.
See Concentrix Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
11/30/2025 |
11/30/2024 |
11/30/2023 |
11/30/2022 |
11/30/2021 |
11/30/2020 |
11/30/2019 |
11/30/2018 |
11/30/2017 |
| Operating Revenue |
$9.83 B |
$9.62 B |
$7.11 B |
$6.32 B |
$5.59 B |
$4.72 B |
$4.71 B |
$2.46 B |
$1.99 B |
| Cost of Revenue |
$6.39 B
|
$6.17 B
|
$4.54 B
|
$4.07 B
|
$3.62 B
|
$3.06 B
|
$2.96 B
|
$1.53 B
|
$1.24 B
|
| Gross Profit |
$3.44 B
|
$3.45 B
|
$2.58 B
|
$2.26 B
|
$1.97 B
|
$1.66 B
|
$1.75 B
|
$937.55 M
|
$749.15 M
|
| Gross Profit Ratio |
0.35
|
0.36
|
0.36
|
0.36
|
0.35
|
0.35
|
0.37
|
0.38
|
0.38
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.83 B
|
$2.85 B
|
$1.92 B
|
$1.62 B
|
$1.40 B
|
$1.35 B
|
$1.45 B
|
$792.79 M
|
$634.53 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.83 B
|
$2.85 B
|
$1.92 B
|
$1.62 B
|
$1.40 B
|
$1.35 B
|
$1.45 B
|
$792.79 M
|
$634.53 M
|
| Cost And Expenses |
$9.22 B
|
$9.02 B
|
$6.45 B
|
$5.68 B
|
$5.01 B
|
$4.41 B
|
$4.41 B
|
$2.32 B
|
$1.88 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$290.35 M
|
$321.83 M
|
$201.00 M
|
$70.08 M
|
$23.05 M
|
$48.31 M
|
$92.20 M
|
$38.24 M
|
$24.02 M
|
| Depreciation & Amortization |
$650.11 M
|
$705.85 M
|
$388.30 M
|
$309.54 M
|
$277.18 M
|
$276.57 M
|
$305.78 M
|
$154.60 M
|
$129.87 M
|
| EBITDA |
-$241.77 M |
$1.33 B |
$997.53 M |
$984.62 M |
$855.92 M |
$592.77 M |
$602.39 M |
$303.75 M |
$242.17 M |
| EBITDA Ratio |
-0.02
|
0.14
|
0.14
|
0.16
|
0.15
|
0.13
|
0.13
|
0.12
|
0.12
|
| Operating Income Ratio |
0.06
|
0.06
|
0.09
|
0.1
|
0.1
|
0.07
|
0.06
|
0.06
|
0.06
|
| Total Other Income/Expenses Net |
-$1.79 B
|
-$297.11 M
|
-$253.10 M
|
-$35.19 M
|
-$16.70 M
|
-$40.87 M
|
-$89.92 M
|
-$33.85 M
|
-$26.35 M
|
| Income Before Tax |
-$1.18 B
|
$299.27 M
|
$408.23 M
|
$605.00 M
|
$555.70 M
|
$267.90 M
|
$204.42 M
|
$110.91 M
|
$88.28 M
|
| Income Before Tax Ratio |
-0.12
|
0.03
|
0.06
|
0.1
|
0.1
|
0.06
|
0.04
|
0.05
|
0.04
|
| Income Tax Expense |
$96.70 M
|
$48.06 M
|
$94.39 M
|
$169.36 M
|
$150.12 M
|
$103.08 M
|
$87.25 M
|
$62.64 M
|
$16.03 M
|
| Net Income |
-$1.28 B
|
$251.22 M
|
$313.84 M
|
$435.05 M
|
$405.58 M
|
$164.81 M
|
$117.16 M
|
$48.27 M
|
$72.25 M
|
| Net Income Ratio |
-0.13
|
0.03
|
0.04
|
0.07
|
0.07
|
0.03
|
0.02
|
0.02
|
0.04
|
| EPS |
-20.36 |
3.72 |
5.72 |
8.34 |
7.78 |
3.19 |
2.27 |
0.94 |
1.4 |
| EPS Diluted |
-20.36 |
3.71 |
5.7 |
8.28 |
7.7 |
3.19 |
2.27 |
0.93 |
1.4 |
| Weighted Average Shares Out |
$63.01 M
|
$64.98 M
|
$53.80 M
|
$51.35 M
|
$51.36 M
|
$51.60 M
|
$51.60 M
|
$51.60 M
|
$51.70 M
|
| Weighted Average Shares Out Diluted |
$63.01 M
|
$65.07 M
|
$54.01 M
|
$51.74 M
|
$51.91 M
|
$51.60 M
|
$51.60 M
|
$51.70 M
|
$51.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
